Why rings of RNA could be the next blockbuster drug

The commercial success of RNA vaccines for COVID-19 has revved up interest in circular RNAs as the next generation of therapies. The commercial success of RNA vaccines for COVID-19 has revved up interest in circular RNAs as the next generation of therapies.

Related Keywords

Beijing , China , Shanghai , Ireland , Colorado , United States , Germany , South Korea , Cambridge , Cambridgeshire , United Kingdom , Seongnam , Kyonggi Do , Ling Chen , Jilin , Massachusetts , Yale University , Connecticut , Boston , California , New Haven , Peking , Copenhagen , Køavn , Denmark , Stanford University , Research Triangle Park , North Carolina , New York , Maryland , Massachusetts Institute Of Technology , Denver , Oliver Rossbach , Jason Rausch , Zefeng Wang , Thomas Kirkegaard Jensen , Alex Wesselhoeft , Wensheng Wei , Oroboros Bio , Dan Anderson , Jake Becraft , Brian Pickering , Howard Chang , Raffaella Squilloni , Aravind Asokan , John Mendlein , Chijian Zuo , Piotr Kowalski , Shanghai Institute Of Biochemistry , University Of Colorado , Duke University In Durham , Suzhou Curemed Biopharma Technology , Stanford University School Of Medicine , University College Cork , Justus Liebig University Of Giessen , Us National Cancer Institute In Frederick , Yale University School Of Medicine , Cell Therapy Institute In Cambridge , Partner Institute For Computational Biology , Nobel Prize , Stanford University School , Orbital Therapeutics , Strand Therapeutics , Grace Chen , Yale University School , Massachusetts Institute , Cancer Institute , Duke University , Torque Bio , Chimerna Therapeutics , New York City , Circode Biomedicine , Aloop Therapeutics , Shanghai Institute , Cell Biology , Justus Liebig University , Peking University , Suzhou Curemed , Partner Institute , Computational Biology , Mass General Brigham Gene , Cell Therapy Institute ,